Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Nathan H. Fowler; Chan Yoon Cheah; Randy D. Gascoyne; John Gribben; Sattva S. Neelapu; Paolo Ghia; Catherine Bollard; Stephen Ansell; Michael Curran; Wyndham H. Wilson; Susan O’Brien; Cliona Grant; Richard Little; Thorsten Zenz; Loretta J. Nastoupil; Kieron Dunleavy

doi:10.3324/haematol.2015.139493

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Nathan H. Fowler, Chan Yoon Cheah, Randy D. Gascoyne, John Gribben, Sattva S. Neelapu, Paolo Ghia, Catherine Bollard, Stephen Ansell, Michael Curran, Wyndham H. Wilson, Susan O’Brien, Cliona Grant, Richard Little, Thorsten Zenz, Loretta J. Nastoupil, Kieron Dunleavy

Hematology

Research output: Contribution to journal › Review article › peer-review

37 Scopus citations

Abstract

The tumor microenvironment is the cellular and molecular environment in which the tumor exists and with which it continuously interacts. In B-cell lymphomas, this microenvironment is intriguing in that it plays critical roles in the regulation of tumor cell survival and proliferation, fostering immune escape as well as the development of treatment resistance. The purpose of this review is to summarize the proceedings of the Second Annual Summit on the Immune Microenvironment in Hematologic Malignancies that took place on September 11-12, 2014 in Dublin, Ireland. We provide a timely overview of the composition and biological relevance of the cellular and molecular microenvironment interface and discuss the role of interactions between the microenvironment and neoplastic cells in a variety of B-cell lymphomas. In addition, we focus on various novel therapeutic strategies that target the tumor microenvironment, including agents that modulate B-cell receptor pathways and immune-checkpoints, chimeric antigen receptor T cells and immunomodulatory agents.

Original language	English (US)
Pages (from-to)	531-540
Number of pages	10
Journal	Haematologica
Volume	101
Issue number	5
DOIs	https://doi.org/10.3324/haematol.2015.139493
State	Published - Apr 30 2016

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2015.139493

Cite this

Fowler, N. H., Cheah, C. Y., Gascoyne, R. D., Gribben, J., Neelapu, S. S., Ghia, P., Bollard, C., Ansell, S., Curran, M., Wilson, W. H., O’Brien, S., Grant, C., Little, R., Zenz, T., Nastoupil, L. J., & Dunleavy, K. (2016). Role of the tumor microenvironment in mature B-cell lymphoid malignancies. Haematologica, 101(5), 531-540. https://doi.org/10.3324/haematol.2015.139493

@article{bdd4be442a954c908ee63729cf5b117b,

title = "Role of the tumor microenvironment in mature B-cell lymphoid malignancies",

abstract = "The tumor microenvironment is the cellular and molecular environment in which the tumor exists and with which it continuously interacts. In B-cell lymphomas, this microenvironment is intriguing in that it plays critical roles in the regulation of tumor cell survival and proliferation, fostering immune escape as well as the development of treatment resistance. The purpose of this review is to summarize the proceedings of the Second Annual Summit on the Immune Microenvironment in Hematologic Malignancies that took place on September 11-12, 2014 in Dublin, Ireland. We provide a timely overview of the composition and biological relevance of the cellular and molecular microenvironment interface and discuss the role of interactions between the microenvironment and neoplastic cells in a variety of B-cell lymphomas. In addition, we focus on various novel therapeutic strategies that target the tumor microenvironment, including agents that modulate B-cell receptor pathways and immune-checkpoints, chimeric antigen receptor T cells and immunomodulatory agents.",

author = "Fowler, {Nathan H.} and Cheah, {Chan Yoon} and Gascoyne, {Randy D.} and John Gribben and Neelapu, {Sattva S.} and Paolo Ghia and Catherine Bollard and Stephen Ansell and Michael Curran and Wilson, {Wyndham H.} and Susan O{\textquoteright}Brien and Cliona Grant and Richard Little and Thorsten Zenz and Nastoupil, {Loretta J.} and Kieron Dunleavy",

note = "Publisher Copyright: {\textcopyright} 2016 Ferrata Storti Foundation.",

year = "2016",

month = apr,

day = "30",

doi = "10.3324/haematol.2015.139493",

language = "English (US)",

volume = "101",

pages = "531--540",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - Role of the tumor microenvironment in mature B-cell lymphoid malignancies

AU - Fowler, Nathan H.

AU - Cheah, Chan Yoon

AU - Gascoyne, Randy D.

AU - Gribben, John

AU - Neelapu, Sattva S.

AU - Ghia, Paolo

AU - Bollard, Catherine

AU - Ansell, Stephen

AU - Curran, Michael

AU - Wilson, Wyndham H.

AU - O’Brien, Susan

AU - Grant, Cliona

AU - Little, Richard

AU - Zenz, Thorsten

AU - Nastoupil, Loretta J.

AU - Dunleavy, Kieron

PY - 2016/4/30

Y1 - 2016/4/30

N2 - The tumor microenvironment is the cellular and molecular environment in which the tumor exists and with which it continuously interacts. In B-cell lymphomas, this microenvironment is intriguing in that it plays critical roles in the regulation of tumor cell survival and proliferation, fostering immune escape as well as the development of treatment resistance. The purpose of this review is to summarize the proceedings of the Second Annual Summit on the Immune Microenvironment in Hematologic Malignancies that took place on September 11-12, 2014 in Dublin, Ireland. We provide a timely overview of the composition and biological relevance of the cellular and molecular microenvironment interface and discuss the role of interactions between the microenvironment and neoplastic cells in a variety of B-cell lymphomas. In addition, we focus on various novel therapeutic strategies that target the tumor microenvironment, including agents that modulate B-cell receptor pathways and immune-checkpoints, chimeric antigen receptor T cells and immunomodulatory agents.

AB - The tumor microenvironment is the cellular and molecular environment in which the tumor exists and with which it continuously interacts. In B-cell lymphomas, this microenvironment is intriguing in that it plays critical roles in the regulation of tumor cell survival and proliferation, fostering immune escape as well as the development of treatment resistance. The purpose of this review is to summarize the proceedings of the Second Annual Summit on the Immune Microenvironment in Hematologic Malignancies that took place on September 11-12, 2014 in Dublin, Ireland. We provide a timely overview of the composition and biological relevance of the cellular and molecular microenvironment interface and discuss the role of interactions between the microenvironment and neoplastic cells in a variety of B-cell lymphomas. In addition, we focus on various novel therapeutic strategies that target the tumor microenvironment, including agents that modulate B-cell receptor pathways and immune-checkpoints, chimeric antigen receptor T cells and immunomodulatory agents.

UR - http://www.scopus.com/inward/record.url?scp=84964768857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964768857&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.139493

DO - 10.3324/haematol.2015.139493

M3 - Review article

C2 - 27132279

AN - SCOPUS:84964768857

SN - 0390-6078

VL - 101

SP - 531

EP - 540

JO - Haematologica

JF - Haematologica

IS - 5

ER -

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this